Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Science. Author manuscript; available in PMC 2005 October 17.
Published in final edited form as:
PMCID: PMC1256034

Hematotoxicity in Workers Exposed to Low Levels of Benzene


Benzene is known to have toxic effects on the blood and bone marrow, but its impact at levels below the U.S. occupational standard of 1 part per million (ppm) remains uncertain. In a study of 250 workers exposed to benzene, white blood cell and platelet counts were significantly lower than in 140 controls, even for exposure below 1 ppm in air. Progenitor cell colony formation significantly declined with increasing benzene exposure and was more sensitive to the effects of benzene than was the number of mature blood cells. Two genetic variants in key metabolizing enzymes, myeloperoxidase and NAD(P)H:quinone oxidoreductase, influenced susceptibility to benzene hematotoxicity. Thus, hematotoxicity from exposure to benzene occurred at air levels of 1 ppm or less and may be particularly evident among genetically susceptible subpopulations.

Benzene causes toxicity to the hematopoietic system (hematotoxicity) and leukemia (1). Exposure to benzene occurs worldwide to workers in the oil, shipping, automobile repair, shoe manufacture, and other industries and to the general public from cigarette smoke, gasoline, and automobile emissions (2). In addition to ongoing concern about health effects at or below the current U.S. occupational standard of 1 ppm, high environmental exposures in cities (3) have led to regulatory consideration of the risks posed by benzene as an air pollutant.

Limitations in previous occupational studies evaluating hematotoxicity at low levels of benzene exposure led us to perform a large cross-sectional study with detailed exposure assessment that measured lymphocyte subsets and colony formation from progenitor cells in addition to the standard blood-count analyses reported in most previous investigations. Because benzene is thought to lower blood cell counts via metabolite effects on hematopoietic progenitor cells (4), we also evaluated the influence of genetic variants in cytochrome P4502E1 (CYP2E1) and myeloperoxidase (MPO), which metabolize benzene to toxic quinones and free radicals (5), and NAD(P)H:quinone oxidoreductase (NQO1), which protects against this toxicity (6, 7).

We compared 250 benzene-exposed shoe workers with 140 unexposed age- and sex-matched controls who worked in three clothes-manufacturing factories in the same region near Tianjin, China. Subjects were young (mean ± SD: 29.9 ± 8.4 years), about two-thirds were female (table S1), and shoe workers had been employed an average of 6.1 ± 2.9 years. For each subject, individual benzene and toluene exposure was monitored repeatedly up to 16 months before phlebotomy, and postshift urine samples were collected from each subject (8, 9). Subjects were categorized into four groups by mean benzene levels measured during the month before phlebotomy [controls, <1 ppm, 1 to <10 ppm, and ≥10 ppm (Table 1)], and more than 100 of the exposed workers had exposures below 1 ppm.

Table 1
Peripheral blood cell counts in relation to benzene exposure level. There are up to 418 observations on 390 unique subjects (140 controls and 250 benzene-exposed workers). Data were obtained from 28 exposed subjects in both years (2000 and 2001) and are ...

All types of white blood cells (WBCs) measured in the Complete Blood Count and platelets (9) were significantly decreased in workers exposed to <1 ppm benzene compared to controls (Table 1). Lymphocyte subset analysis showed significantly decreased CD4+–T cells, CD4+/CD8+ ratio, and B cells. Hemoglobin concentrations were decreased only among workers exposed to ≥10 ppm. Tests for a linear trend using benzene air level as a continuous variable were significant for platelets and all WBC measures except monocytes and CD8+–T cells (Table 1). Adjustment for a range of potential confounders had a negligible effect on the strength of the associations (9).

We then restricted the linear-trend analyses to workers exposed to <10 ppm benzene, excluding controls and higher exposed workers, and found that inverse associations remained for total WBCs (P = 0.013), granulocytes (P = 0.02), lymphocytes (P = 0.045), B cells (P = 0.018), and platelets (P = 0.0016). To address the influence of past benzene exposure on these cell types, we examined workers exposed to mean benzene <1 ppm over the previous year (n = 60), and a subset who also had <40-ppm-years lifetime cumulative benzene exposure (n = 50), and found that the above cell types were decreased compared to controls (P < 0.05). Finally, to exclude the effect of other potential exposures on these associations, we identified a group of workers exposed to <1 ppm benzene with negligible exposure to other solvents (n = 30) (fig. S1) (9) and found decreased levels of WBCs, granulocytes, lymphocytes, and B cells compared to controls (P < 0.05). These findings, based on differentiated blood cell counts, provide evidence of hematotoxicity in workers exposed to benzene at or below 1 ppm.

Because benzene affected nearly all blood cell types, toxicity to progenitor cells was suspected. A fraction of hematopoietic progenitor cells circulate in the bloodstream in dynamic equilibrium with the bone marrow and can be cultured in colony-forming assays to measure their proliferative potential (10). Using peripheral blood from 29 benzene-exposed workers and 24 matched controls, we examined the dose-dependent effects of benzene on different types of progenitor cell colony formation (CFU-GM, BFU-E, CFU-GEMM) (9). Highly significant dose-dependent decreases in colony formation from progenitor cells were observed (Fig. 1). Further, benzene caused a greater proportional decrease in colony formation than in levels of differentiated WBCs and granulocytes (compare Fig. 1, B and C, to Fig. 1A), suggesting that early progenitor cells are more sensitive than are mature cells to the hematotoxic effects of benzene. This greater sensitivity of early progenitor cells is in agreement with previous findings in human cell cultures and mice (11, 12).

Fig. 1
Effect of benzene exposure on (A) white blood cell (WBC) and granulocyte counts; (B) colonies from the colony-forming unit–granulocyte-macrophage (CFU-GM) and burst-forming unit–erythroid (BFU-E); and (C) colonies from the colony-forming ...

Genetic variation in enzymes responsible for activating and detoxifying benzene has been shown to confer susceptibility to benzene poisoning in highly exposed workers (6, 13, 14). We examined four nonsynonymous single-nucleotide polymorphisms (SNPs), with probable functional significance, in the CYP2E1, MPO, and NQO1 genes (9). Two genotypes significantly influenced WBC counts in benzene-exposed workers, MPO –463GG (rs2333227) (P = 0.04) and NQO1 465CT (rs4986998) (P = 0.014) (table S2). In exposed subjects who carry either one (n = 191) or both of the “at risk” genotypes (n = 11), there was a strong gene-dosage effect (Ptrend = 0.004) (table S3), which was also present among those exposed to <1 ppm (Ptrend = 0.003). Compared to a mean ± SD WBC count of 5980 ± 1420 cells/μl among subjects with neither “at risk” genotype, the WBC count was 5480 ± 1120 cells/μl among subjects with either “at risk” genotype (P = 0.006) and 4900 ± 1240 cells/μl (P = 0.039) for both genotypes, in subjects exposed to <1 ppm. Neither genotype was associated with WBC count in controls, either separately (table S2) or in combination (Ptrend = 0.94) (table S3), and the trends in exposed workers and controls were significantly different from each other (test for interaction, P = 0.03). Subjects with the MPO –463GG genotype have normal expression and had a greater decrease in WBC counts from benzene exposure compared to individuals with the GA or AA genotypes (the latter two being associated with reduced expression) (15). The functional significance of the NQO1 465C>T SNP is less clear, but it may increase alternative splicing and lower expression, thereby enhancing benzene hematotoxicity, as we observed. The other two SNPs [CYP2E1 –1053C>T (rs2031920) and NQO1 609C>T (rs1800566)] were not significantly related to WBCs (table S2).

There have been numerous studies of benzene-induced hematotoxicity (, but few have been able to study effects at low levels of exposure. Ward et al. (16) found no evidence of a threshold for hematotoxic effects of benzene and suggested that exposure to <5 ppm benzene could result in hematologic suppression. Occupational exposure decreased WBCs in petrochemical workers exposed to <10 ppm benzene (17), and Qu et al. reported that WBCs and other cell types were decreased in workers exposed to <5 ppm benzene (18). In contrast, Collins et al. (19, 20) and Tsai et al. (21) did not detect decreased blood cell counts based on routine monitoring of workers exposed to low levels of benzene.

The present study showed that total WBCs, granulocytes, lymphocytes, B cells, and platelets significantly declined with increasing benzene exposure and were lower in workers exposed to benzene at air levels of 1 ppm or less compared to controls. Our findings are particularly robust because we carried out extensive exposure assessment over a 16-month period (8) and linked individual air-monitoring data to the endpoints measured. Further, we showed that benzene exposure decreased colony formation from myeloid progenitor cells, and that these progenitors were more sensitive to benzene toxicity than were mature WBCs. Finally, genetic variation in MPO and NQO1 conferred susceptibility to benzene-induced lowering of WBC counts. Although confirmation of these findings in other studies is needed, these data provide evidence that benzene causes hematologic effects at or below 1 ppm, particularly among susceptible subpopulations.


Supporting Online Material, Materials and Methods, SOM Text, Fig. S1, Tables S1 to S3., References


1. Aksoy M. Environ Health Perspect. 1989;82:193. [PMC free article] [PubMed]
2. Gist GL, Burg JR. Toxicol Ind Health. 1997;13:661. [PubMed]
3. Simon V, et al. Sci Total Environ. 2004;334–335:177. [PubMed]
4. Yoon BI, et al. Exp Hematol. 2001;29:278. [PubMed]
5. Ross D. Eur J Haematol Suppl. 1996;60:111. [PubMed]
6. Rothman N, et al. Cancer Res. 1997;57:2839. [PubMed]
7. Bauer AK, et al. Cancer Res. 2003;63:929. [PubMed]
8. Vermeulen R, et al. Ann Occup Hyg. 2004;48:105. [PubMed]
9. Materials and methods are available as supporting material on Science Online.
10. Kreja L, Greulich KM, Fliedner TM, Heinze B. Int J Radiat Biol. 1999;75:1241. [PubMed]
11. Smith MT, et al. Carcinogenesis. 2000;21:1485. [PubMed]
12. Abernethy DJ, Kleymenova EV, Rose J, Recio L, Faiola B. Toxicol Sci. 2004;79:82. [PubMed]
13. Wan J, et al. Environ Health Perspect. 2002;110:1213. [PMC free article] [PubMed]
14. Xu JN, et al. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2003;21:86. [PubMed]
15. Winterbourn CC, Vissers MC, Kettle AJ. Curr Opin Hematol. 2000;7:53. [PubMed]
16. Ward E, et al. Am J Ind Med. 1996;29:247. [PubMed]
17. Zhang B. Zhonghua Yu Fang Yi Xue Za Zhi. 1996;30:164. [PubMed]
18. Qu Q, et al. Am J Ind Med. 2002;42:275. [PubMed]
19. Collins JJ, et al. J Occup Med. 1991;33:619. [PubMed]
20. Collins JJ, Ireland BK, Easterday PA, Nair RS, Braun J. J Occup Environ Med. 1997;39:232. [PubMed]
21. Tsai SP, et al. Regul Toxicol Pharmacol. 2004;40:67. [PubMed]
22. Zeger SL, Liang KY. Biometrics. 1986;42:121. [PubMed]
23. We thank the participants for taking part in this study. Supported by NIH grants RO1ES06721, P42ES04705, and P30ES01896 (M.T.S.), P42ES05948 and P30ES10126 (S.M.R.), and NIH contract N01-CO-12400 with SAIC-Frederick, Inc. M.T.S. has received consulting and expert testimony fees from law firms representing both plantiffs and defendants in cases involving exposure to benzene. G.L. has received funds from the American Petroleum Institute for consulting on benzene-related health research.